Results 291 to 300 of about 160,832 (337)

Exploring the impact of first-line durvalumab plus chemotherapy on advanced biliary tract cancer: a systematic review and meta-analysis. [PDF]

Oncologist
Reimann P, Schneider EM, Djanani A, Mink S, Winder T, Benda M.   +5 more
europepmc   +1 more source

Single-Arm Pivotal Studies in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer. [PDF]

J Clin Oncol
Bandari J, Messing EM.
europepmc   +1 more source

Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer

Carlo Lazzaro
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gemcitabine

Reactions Weekly, 2002
Ines Mader, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, Sabine M. Wassertheurer   +5 more
  +5 more sources

Gemcitabine

Reactions Weekly, 2016
  +5 more sources

Gemcitabine

Reactions Weekly, 2011
  +5 more sources

Gemcitabine

Reactions Weekly, 2018
  +4 more sources

Gemcitabine

Reactions Weekly, 2021
openaire   +2 more sources

Gemcitabine

Reactions Weekly, 2023
openaire   +2 more sources

Gemcitabine

Reactions Weekly, 2015
  +4 more sources